NON-SMALL CELL LUNG CANCER STAGE IV

This adverse event was reported 365 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER STAGE IV:

# Drug Count
0 CERITINIB 90
1 CARBOPLATIN 46
2 CRIZOTINIB 25
3 PACLITAXEL 24
4 PEMETREXED DISODIUM 23
5 PACLITAXEL (AIBUMIN-BOUND) 19
6 PEMBROLIZUMAB 19
7 PEMETREXED 19
8 METHOTREXATE SODIUM 14
9 OMEPRAZOLE MAGNESIUM 14
See all common drugs associated with NON-SMALL CELL LUNG CANCER STAGE IV

NON-SMALL CELL LUNG CANCER STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CERITINIB 90 0.0378
1 CAPMATINIB 6 0.0025
2 DATOPOTAMAB DERUXTECAN 2 0.0023
3 SOTORASIB 7 0.0020
4 CRIZOTINIB 25 0.0020
5 BRIGATINIB 6 0.0016
6 ERLOTINIB HYDROCHLORIDE 13 0.0010
7 LORLATINIB 5 0.0007
8 RAMUCIRUMAB 4 0.0006
9 PEMETREXED DISODIUM 23 0.0006
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER STAGE IV